Data assessment | Screening | Baseline Week 0 | Dose adjustment 1 Week 2 | Dose adjustment 2 Week 4 | Dose adjustment 3 Week 8 | On treatment Week 26 | Last dose Week 52 | Follow-up Week 64 |
---|---|---|---|---|---|---|---|---|
hCG-stimulation test | x | |||||||
Blood pressure | x | x | x | x | x | x | x | x |
Blood samples | x | x | x | x | x | x | x | x |
Waist circumference | x | x | x | x | ||||
DXA scan | x | x | x | x | ||||
Oral glucose tolerance test | x | x | x | x | ||||
Questionnaires | x | x | x | x | ||||
Anogenital distance | x | x | ||||||
Randomization | x | |||||||
On treatment | x | x | x | x | x | x | ||
Dose adjustment | x | x | x | |||||
Evaluation of side effects | x | x | x | x | x | x | x |